Skip to main content
Fig. 7 | Biology Direct

Fig. 7

From: RARRES1 inhibits hepatocellular carcinoma progression and increases its sensitivity to lenvatinib through interaction with SPINK2

Fig. 7

RARRES1 suppressed tumor growth in vivo and increased sensitivity to lenvatinib. (A) Tumor sizes in four groups of Huh7 xenografts treated with Ctrl, RARRES1, lenvatinib, and RARRES1 + lenvatinib. (B) The tumor growth curves were generated for each group by measuring tumor volumes every three days. (C) Weights of tumors dissected from mice in the four groups. *P < 0.05, ***P < 0.001

Back to article page

Biology Direct

ISSN: 1745-6150

Contact us